X, L., X, Z., X, Q., X, M., & K, X. (2021). Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Dove Medical Press.
Style de citation Chicago (17e éd.)X, Liu, Zhu X, Qi X, Meng X, et Xu K. Co-Administration of IRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)X, Liu, et al. Co-Administration of IRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.